Radiosurgical management of pathology-proven low-grade glioma: a systematic review across the pre- and post-molecular classification era
SRS offers a non-invasive management option for selected LGGs with durable control and acceptable safety. Prognosis appears to be influenced by treatment history, including prior radiotherapy and surgical management. Lack of molecular stratification highlights the need for studies focused on IDH (isocitrate dehydrogenase)-mutant LGGs to clarify the role of SRS in the molecular era.
Authors
- Armine T. Tayag
- Fred C. Lam
- J. Liu
- Daniel J. Park (ORCID: https://orcid.org/0000-0002-6354-0931)
- Yusuke S. Hori (ORCID: https://orcid.org/0000-0001-9921-6810)
- Sara Coleman Emrich
- Ruchit Jain (ORCID: https://orcid.org/0009-0001-9594-7453)
- Yuka Mizutani
- Steven D. Chang (ORCID: https://orcid.org/0000-0002-4315-681X)
- Muhammad Izhar (ORCID: https://orcid.org/0009-0002-1604-2494)
- Louisa Ustrzynski
- Paul M Harary
- Shreyas Annagiri
- D. Reesh
Institutions
- Stanford Medicine (US)
- Nagoya University (JP)
- Stanford University (US)
Publication Details
- Journal
- Journal of Neurosurgical Sciences
- Published
- 2025-12-09
- DOI
- https://doi.org/10.23736/s0390-5616.25.06656-1
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00